Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Arkh Patol ; 66(2): 7-10, 2004.
Article in Russian | MEDLINE | ID: mdl-15154374

ABSTRACT

We examined 39 women with normal endometrium and 139 women with glandular-cystic hyperplasia of the endometrium (without atypia). According to clinical manifestations of hyperplasia, the patients were divided into 3 groups: 74 (53%) had reestablishing menstrual function after total curettage (group 1); 42 patients (30%) with glandular-cystic hyperplasia after curettage and hormonal therapy with progesterone and synthetic progestins (duration 3 to 6 months) had no repeated pathology of the endometrium (group 2); endometrial hyperplasia recurred 2 and 3 times as showed biopsies during 2-5 years of observation in 23 (17%) women (group 3). Immunohistochemical tests of normal endometrium revealed correlations between stages of menstrual cycle and steroid hormone receptors in nuclei of glandular epithelium and stromal cells. Maximum sensitivity of glandular epithelium to estrogen and pronounced expression of estrogenic receptors were observed at middle and late stages of proliferation. High sensitivity of glandular epithelium to progesterone was registered at middle and late stages of proliferation and early stage of secretion. Two types of hormone receptor expression were observed. Type 1 typical for the endometrium of middle and late stage of proliferation was characterised by a high content of receptors to E2 and P in glandular epithelium and stromal cells. Type 2 was observed in patients with recurring glandular hyperplasia and was characterised by a mosaic picture up to complete absence of receptor expression in nuclei of some glands and stromal cells. The detected zones free of receptors to estrogens and progesterone evidence for local disturbance of a regulating role of signal pathways of sexual steroids and can serve a substrate for formation of tissue autonomy.


Subject(s)
Endometrial Hyperplasia/metabolism , Estrogens/metabolism , Hormone Replacement Therapy , Progesterone/metabolism , Receptors, Steroid/metabolism , Adult , Cell Division , Endometrial Hyperplasia/immunology , Endometrial Hyperplasia/pathology , Endometrium/metabolism , Female , Follow-Up Studies , Humans , Hyperplasia/pathology , Immunohistochemistry , Menstrual Cycle , Middle Aged , Receptors, Estrogen/immunology , Receptors, Estrogen/metabolism , Receptors, Progesterone/immunology , Receptors, Progesterone/metabolism , Receptors, Steroid/immunology
2.
Bull Exp Biol Med ; 135(1): 77-80, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12717520

ABSTRACT

No appreciable disorders of cellular immunity were detected in patients with glandular cystic endometrial hyperplasia. Atypical endometrial hyperplasia was associated with quantitative changes in T lymphocytes and their subpopulations, decreased level of lymphocytes carrying activation antigens, and increased count of natural killers. These changes can be characterized as immunocompensation.


Subject(s)
Climacteric/immunology , Endometrial Hyperplasia/immunology , T-Lymphocytes/immunology , Adult , Female , Humans , Immunity, Cellular , Killer Cells, Natural/immunology , Lymphocyte Count , Middle Aged , T-Lymphocytes/pathology
3.
Arkh Patol ; 64(6): 27-30, 2002.
Article in Russian | MEDLINE | ID: mdl-12534224

ABSTRACT

53 histological slides obtained from 4 patients aged 35-68 years with diagnosis of uterine carcinoma without invasion (16 patients) and tumor invasion into uterine muscular membrane (24 patients) were retrospectively analyzed. On the basis of morphometry and ploidometry of 2989 nuclei on the image analyzer Imager-CG (Russia) with a computer program Avtan-San, a complex of diagnostic criteria characterizing the grade of malignancy of uterine tumors was obtained. Differential diagnostic ploidometric characteristics of 4 degrees of tumor progression are described. With the process intensification the amount of genetic material in tumor cell nuclei increase 1.7-fold, proliferative activity 2.2-fold, number of polyploid cells--1.5-fold. These data specify the degree of differentiation of uterine body adenocarcinoma and help to plan treatment policy for patients with uterine carcinoma.


Subject(s)
Adenocarcinoma/genetics , Ploidies , Uterine Neoplasms/genetics , Uterus/ultrastructure , Adenocarcinoma/ultrastructure , Adult , Aged , Cell Differentiation , Cell Nucleus/genetics , Cell Nucleus/ultrastructure , Female , Humans , Middle Aged , Retrospective Studies , Uterine Neoplasms/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...